Professional Documents
Culture Documents
in contact with the individual will not be exposed to radiation as long as good hygiene practices are used. Who Should Receive Xofigo? Xofigo is only approved for men with prostate cancer that has not previously responded to medications that deprive the body of hormones that otherwise fuel prostate cancer growth. To be eligible for Xofigo, the individual must also have symptoms related to the spread of prostate cancer to the bone. Benefits Of Xofigo Versus Standard Chemotherapy Prior to the approval of Xofigo, patients with non-responsive prostate cancer were placed on injectable chemotherapy medications. The chemotherapy travels throughout the body, resulting in the death of any cells that are rapidly dividing both cancerous and healthy. It is the death of normal cells that causes the commonly seen side effects of chemotherapy, including severe nausea, vomiting, diarrhea, hair loss, rash, mouth sores, and destruction of blood cells that work to fight infection. Since Xofigo specifically targets cancer cells in the bone, there are fewer side effects than traditional chemotherapy medications. The most common side effects seen in clinical trials for Xofigo were nausea, diarrhea, vomiting, and swelling. A course of treatment is also only six injections that are four weeks apart, reducing the duration of treatment needed. Additionally, it was found that patients taking Xofigo lived 3.6 months longer than patients on standard treatment in the clinical trial. Therefore, this novel medication is not only a safer option, but also has the potential to prolong the lives of men with prostate cancer. For more information, contact Michele Rice, Director, Pharmacy and Research, at 309-243-3407. Visit our website today: www.illinoiscancer.com.
We Dispense Health
309.681.8850
Anti-Aging and Bio-identical Hormones Feeling your best throughout life no matter your age!
Have you ever wondered what happens to our bodies as we age? Learn to optimize organ functions and balance hormones with natural, over-the-counter, and bioidentical options.
Seating Limited Call to Reserve Your Seat 6:30pm Thursday, July 25th 2013 @ Hult Health Education Center 5215 N Knoxville Ave - Peoria, IL 61614
www.essentialwellnesspharmacy.com
Page 42 Healthy Cells Magazine Peoria July 2013